SUGAR LAND--November 8, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--It may be getting chilly in New England, but the life science industry continues to heat up the region with major capital investment. According to a recent analysis of Industrial Info's Pharmaceutical-Biotech Industry platform, the New England region is set to launch 15 projects, with a total investment value (TIV) of $1.4 billion, before the end of the year. The region has long been a favorite of the industry, hosting an impressive roster of the top biotech and pharmaceutical companies, along with nascent but promising start-ups.

Within this article: Details on some of the top-valued pharma and biotech projects set to begin construction in the New England region in the final quarter of 2016.